A Study to Compare PK, PD and Safety of the AD-214 and AD-2141
NCT05062876 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 41
Last updated 2022-07-20
Summary
A study to compare safety, pharmacokinetics and pharmacodynamics of AD-214 to AD-2141 in healthy volunteers.
Conditions
- Gastroesophageal Reflux Disease
Interventions
- DRUG
-
AD-214
1 tablet administered before the breakfast during 7 days
- DRUG
-
AD-2141
1 tablet administered before the breakfast during 7 days
Sponsors & Collaborators
-
Addpharma Inc.
lead INDUSTRY
Principal Investigators
-
Seunghwan Lee, M.D.,Ph.D · Seoul National University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 19 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-11-01
- Primary Completion
- 2022-03-17
- Completion
- 2022-03-29
Countries
- South Korea
Study Locations
More Related Trials
-
A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-120 and AD-120A
NCT06916130 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole
NCT03980756 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of AD-203
NCT04066530 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare PK, PD and Safety of UI058 and UIC202004 in Healthy Subjects
NCT05282914 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3)
NCT03736369 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of UI059 and UIC202201 in Healthy Subjects
NCT06141577 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effect of Gastric pH on Acalabrutinib Pharmacokinetics (PK) in Healthy Adult Participants
NCT04905043 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects
NCT03211143 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" Under Fasting Conditions in Healthy Adult Volunteers
NCT05959486 ·Status: COMPLETED ·Phase: PHASE1
-
A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis.
NCT00206284 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare PK and Safety of CKD-381 and D026 in Healthy Male Subjects
NCT03444402 ·Status: COMPLETED ·Phase: PHASE1
-
ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD)
NCT00810485 ·Status: COMPLETED ·Phase: PHASE2
-
A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium
NCT00125736 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Effect of Antacid and Multivitamin and Mineral Tablet on the Study Drug GSK1349572
NCT00858455 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer
NCT05656092 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis
NCT05024721 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)
NCT03561090 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of DA9601 for Acute and Chronic Gastritis and to Determine the Optimal Clinical Dosage and Administration
NCT07139886 ·Status: COMPLETED ·Phase: PHASE2
-
Investigate a Pharmacokinetics Between S-pantoprazole 20mg and Pantoprazole 40mg in Healthy Male Subjects
NCT01821521 ·Status: UNKNOWN ·Phase: PHASE1
-
Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users
NCT02342470 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacodynamic and Pharmacokinetic Study of E3710 Following Oral Administration to Healthy, Male, Japanese Subjects
NCT01390714 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Determine the Relative Bioavailability of Capsule and Tablet Formulations of GDC-0941 and the Effect of Food and Proton Pump Inhibition on GDC-0941 Tablet Pharmacokinetics in Healthy Volunteers
NCT00999128 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis
NCT05604261 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of YPI 011 to Rabeprazole in Healthy Adult Subjects
NCT04703868 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers
NCT02757144 ·Status: COMPLETED ·Phase: PHASE1